Active Implantable Devices Market

Active implantable medical devices are powered devices that are inserted into a patient s body, through either a natural orifice or by surgical means, and are intended to remain in the patient s body after the procedure. Such devices are usually battery powered, and the power supply can either be contained in the instrument or be connected to wires that protrude from the patient s body.

Active Implantable Devices Market contains market size and forecasts of Active Implantable Devices in global, including the following market information:

• Global Active Implantable Devices Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Active Implantable Devices Market Sales, 2017-2022, 2023-2028, (Units)
• Global top five Active Implantable Devices companies in 2021 (%)

The global Active Implantable Devices market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Implantable Cardioverter Defibrillator Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Active Implantable Devices include LivaNova PLC(U.K.), MED-EL(Austria), Medtronic(Ireland), Abbott Laboratories(U.S.), BIOTRONIK(Germany), Boston Scientific Corporation(U.S.), Cochlear Limited(Australia), Nurotron Biotechnology(China) and Sonova Holding Switzerland) and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Active Implantable Devices manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Active Implantable Devices Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Units)

Global Active Implantable Devices Market Segment Percentages, by Type, 2021 (%)

• Implantable Cardioverter Defibrillator
• Implantable Cardiac Pacemakers
• Ventricular Assist Devices
• Implantable Heart Monitors/Insertable Loop Recorders
• Neurostimulators
• Implantable Hearing Devices

Global Active Implantable Devices Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Units)

Global Active Implantable Devices Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Clinic

Global Active Implantable Devices Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Units)

Global Active Implantable Devices Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Active Implantable Devices revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Active Implantable Devices revenues share in global market, 2021 (%)
• Key companies Active Implantable Devices sales in global market, 2017-2022 (Estimated), (Units)
• Key companies Active Implantable Devices sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• LivaNova PLC(U.K.)
• MED-EL(Austria)
• Medtronic(Ireland)
• Abbott Laboratories(U.S.)
• BIOTRONIK(Germany)
• Boston Scientific Corporation(U.S.)
• Cochlear Limited(Australia)
• Nurotron Biotechnology(China)
• Sonova Holding Switzerland)
• William Demant Holding(Denmark)